Topological analysis of SARS CoV-2 main protease

Area of Science:

• Virology
• Structural Biology
• Drug Discovery

Background:

• The COVID-19 pandemic necessitates novel therapeutics against SARS-CoV-2.
• The SARS-CoV-2 main protease (Mpro) is crucial for viral replication and a key drug target.
• Mpro shares structural similarities with the main protease of SARS-CoV-1.

Purpose of the Study:

• To compare the structural dynamics and sensitivity of SARS-CoV-2 Mpro versus SARS-CoV-1 Mpro.
• To identify regions within SARS-CoV-2 Mpro that are most sensitive to structural perturbations.
• To inform the design of potent inhibitors targeting SARS-CoV-2 Mpro.

Main Methods:

• Utilized a simplified residue network model to represent protein structures.
• Analyzed the transmission of structural changes across the protein.
• Investigated long-range interactions influencing protein sensitivity.

Main Results:

• SARS-CoV-2 Mpro exhibits 1900% greater sensitivity to structural changes than SARS-CoV-1 Mpro.
• The catalytic site (Cys-145) of SARS-CoV-2 Mpro is the region most sensitive to perturbations.
• This highly sensitive region overlaps with the binding sites of known potent inhibitors.

Conclusions:

• SARS-CoV-2 Mpro's heightened sensitivity presents a significant advantage for therapeutic intervention.
• Targeting the catalytic site Cys-145 is a viable strategy for developing effective SARS-CoV-2 inhibitors.
• The findings provide a structural basis for designing next-generation antiviral drugs against COVID-19.